Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Mucosal Immunol ; 10(4): 946-956, 2017 07.
Article in English | MEDLINE | ID: mdl-27966553

ABSTRACT

Intestinal IgA, which is regulated by gut microbiota, has a crucial role in maintenance of intestinal homeostasis and in protecting the intestines from inflammation. However, the means by which microbiota promotes intestinal IgA responses remain unclear. Emerging evidence suggests that the host can sense gut bacterial metabolites in addition to pathogen-associated molecular patterns and that recognition of these small molecules influences host immune response in the intestines and beyond. We reported here that microbiota metabolite short-chain fatty acid acetate promoted intestinal IgA responses, which was mediated by "metabolite-sensing" GPR43. GPR43-/- mice demonstrated lower levels of intestinal IgA and IgA+ gut bacteria compared with those in wild type (WT) mice. Feeding WT but not GPR43-/- mice acetate but not butyrate promoted intestinal IgA response independent of T cells. Acetate promoted B-cell IgA class switching and IgA production in vitro in the presence of WT but not GPR43-/- dendritic cells (DCs). Mechanistically, acetate-induced DC expression of Aldh1a2, which converts Vitamin A into its metabolite retinoic acid (RA). Moreover, blockade of RA signaling inhibited the acetate induction of B-cell IgA production. Our studies thus identified a new pathway by which microbiota promotes intestinal IgA response through its metabolites.


Subject(s)
Acetates/metabolism , Dendritic Cells/immunology , Fatty Acids, Volatile/metabolism , Intestines/immunology , Microbiota/immunology , Receptors, G-Protein-Coupled/metabolism , Acetates/chemistry , Acetates/immunology , Aldehyde Dehydrogenase 1 Family , Animals , Butyrates/chemistry , Butyrates/immunology , Butyrates/metabolism , Cells, Cultured , Fatty Acids, Volatile/chemistry , Fatty Acids, Volatile/immunology , Female , Immunity, Mucosal , Immunoglobulin A/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Receptors, G-Protein-Coupled/genetics , Retinal Dehydrogenase/metabolism , Tretinoin/metabolism , Vitamin A/metabolism
2.
Mucosal Immunol ; 8(5): 1072-82, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25586558

ABSTRACT

Commensal microbiota-specific T helper type 17 (Th17) cells are enriched in the intestines, which can convert into T follicular helper (Tfh) in Peyer's patches, and are crucial for production of intestinal immunoglobulin A (IgA) against microbiota; however, the role of Th17 and Tfh cytokines in regulating the mucosal IgA response to enteric microbiota is still not completely known. In this study, we found that intestinal IgA was impaired in mice deficient in interleukin (IL)-17 or IL-21 signaling. IL-21, but not IL-17, is able to augment B-cell differentiation to IgA(+) cells as mediated by transforming growth factor ß1 (TGFß1) and accelerate IgA class switch recombination (CSR). IL-21 and retinoic acid (RA) induce IgA(+) B-cell development and IgA production and drives autocrine TGFß1 production to initiate IgA CSR. Repletion of T-cell-deficient TCRßxδ(-/-) mice with Th17 cells specific for commensal bacterial antigen increased the levels of IgA(+) B cells and IgA production in the intestine, which was blocked by neutralizing IL-21. Thus IL-21 functions to strongly augment IgA production under intestinal environment. Furthermore, IL-21 promotes intestinal B-cell homing through α4ß7 expression, alone or with TGFß and RA. Together, IL-21 from microbiota-specific Th17 and/or Tfh cells contributes to robust intestinal IgA levels by enhancing IgA(+) CSR, IgA production and B-cell trafficking into the intestine.


Subject(s)
Gastrointestinal Microbiome/immunology , Immunity, Mucosal/physiology , Immunoglobulin A/immunology , Interleukins/immunology , Intestinal Mucosa/immunology , Animals , B-Lymphocytes/immunology , Cell Differentiation/genetics , Cell Differentiation/immunology , Cell Movement/genetics , Cell Movement/immunology , Immunoglobulin A/genetics , Interleukin-17/genetics , Interleukin-17/immunology , Interleukins/genetics , Intestinal Mucosa/microbiology , Mice , Mice, Knockout , Receptors, Antigen, T-Cell, gamma-delta/genetics , Receptors, Antigen, T-Cell, gamma-delta/immunology , Th17 Cells/immunology , Transforming Growth Factor beta1/genetics , Transforming Growth Factor beta1/immunology
3.
Appl Environ Microbiol ; 72(2): 1653-62, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16461722

ABSTRACT

Xenorhabdus and Photorhabdus are gram-negative bacteria that produce a range of proteins that are toxic to insects. We recently identified a novel 42-kDa protein from Xenorhabdus nematophila that was lethal to the larvae of insects such as Galleria mellonella and Helicoverpa armigera when it was injected at doses of 30 to 40 ng/g larvae. In the present work, the toxin gene txp40 was identified in another 59 strains of Xenorhabdus and Photorhabdus, indicating that it is both highly conserved and widespread among these bacteria. Recombinant toxin protein was shown to be active against a variety of insect species by direct injection into the larvae of the lepidopteran species G. mellonella, H. armigera, and Plodia interpunctella and the dipteran species Lucilia cuprina. The protein exhibited significant cytotoxicity against two dipteran cell lines and two lepidopteran cell lines but not against a mammalian cell line. Histological data from H. armigera larvae into which the toxin was injected suggested that the primary site of action of the toxin is the midgut, although some damage to the fat body was also observed.


Subject(s)
Bacterial Proteins/pharmacology , Bacterial Toxins/pharmacology , Insecta/drug effects , Photorhabdus/genetics , Photorhabdus/physiology , Xenorhabdus/genetics , Xenorhabdus/physiology , Animals , Bacterial Proteins/biosynthesis , Bacterial Proteins/genetics , Bacterial Toxins/biosynthesis , Bacterial Toxins/genetics , Base Sequence , Cell Line , DNA, Bacterial/genetics , Digestive System/drug effects , Digestive System/pathology , Fat Body/drug effects , Fat Body/pathology , Genes, Bacterial , Lepidoptera/drug effects , Molecular Sequence Data , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Recombinant Proteins/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL